INTRODUCTION Dr. Ahmed Farrag is a hematology and internal medicine specialist at the Thalassemia Centre at Latifa Women and Children...
thalassemia
Today represents a key milestone for beta-thalassemia patients battling hereditary chronic disease. This comes after the approval that was granted...
The Food and Drug Administration (FDA) has given bluebird bio the green light to resume its clinical trials of gene therapy, LentiGlobin....
It seems that the hope of gene therapy for transfusion-dependent β-thalassemia (TDT) is becoming so close. During the 62nd American Society...
Beta thalassemias is an inherited blood disorder that results from the reduced or absent synthesis of the beta chains of hemoglobin....
Alpha-thalassemia is a type of thalassemia that involves the HBA1 and HBA2 genes. This inherited blood disorder results from impaired production of...
